EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Insomnia Symptoms in a Swiss Population‐Based Cohort: Prevalence, Clinical Correlates and Polysomnographic Alterations

Isabel Ericson iD, Geoffroy Solelhac iD, Théo Imler iD, Kari Lambing iD, Magdy Younes iD, Pedro Marques-Vidal iD, Peter Vollenweider iD, Marie-Pierre Françoise Strippoli iD, Martin Preisig iD, Raphaël Heinzer iD, Nicola A Marchi iD

Journal of Sleep Research · 2026-10 · 35 (5)

DOI: 10.1111/jsr.70376 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Sleep Research, online erschienen am 04.06.2026. Verfasst von Isabel Ericson und 10 weiteren Autor:innen. Beteiligte Einrichtung: Center for Investigation and Research on Sleep, Department of Medicine, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerlan…. Hauptthemen laut MEDLINE: Sleep Initiation and Maintenance Disorders, Polysomnography. Die Arbeit nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: GlaxoSmithKline, University of Lausanne (Faculty of Biology and Medicine), Swiss Personalized Health Network.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study assessed the prevalence, clinical correlates and polysomnographic features of insomnia symptoms in a population‐based cohort (HypnoLaus, Lausanne, Switzerland). Data were obtained from 3947 participants (mean age 57.5 ± 10.5 years; range 40–82; 52.0% female). Insomnia symptoms were defined as difficulty initiating or maintaining sleep ≥ 3 nights/week during the past month or regular hypnotic use. Independent correlates of insomnia symptoms were examined using logistic regression. In the subset of 1718 participants who underwent polysomnography (performed 1.1 ± 0.9 years after insomnia symptom assessment), associations between insomnia symptoms and sleep variables were examined using linear regression models adjusted for age, sex, depression, anxiety and psychotropic use. Insomnia symptoms affected 32.0% of participants, and 4.2% of the total sample reported regular hypnotic use. Independent correlates included older age, female sex, lower education, dyslipidaemia, lower likelihood of current smoking, excessive alcohol consumption, depression, anxiety, psychotropic use and daytime sleepiness. Compared with those without symptoms, participants with insomnia showed shorter total sleep time, longer sleep onset latency, longer wake after sleep onset and lower sleep efficiency (all small effect sizes). Sleep microstructure analysis showed higher odds ratio product (ORP) values (in wake, NREM, and N2, and ORP‐9), higher normalised EEG power, higher beta power and higher gamma power (all small effect sizes). Insomnia symptoms are highly prevalent in this population‐based cohort and are linked to multiple sociodemographic and clinical factors. Polysomnographic findings indicate modest sleep macrostructural differences, whereas microstructural alterations, although subtle in magnitude, appeared more consistently associated with insomnia symptoms.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Sleep Initiation and Maintenance DisordersPolysomnographyHumansFemaleMaleSwitzerlandPrevalenceAgedMiddle AgedCohort StudiesAdultAged, 80 and overSleep DurationHypnotics and Sedatives

Stichwörter der Autor:innen

EEG spectral analysisepidemiologyhypnoticsodds ratio productpolysomnographysleep microstructure

Substanzen

Hypnotics and Sedatives

Autor:innen und Institutionen

  • Center for Investigation and Research on Sleep, Department of Medicine, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
  • YRT Limited, Winnipeg, Manitoba, Canada.
  • Department of Psychology, Brock University, St Catharines, Ontario, Canada.
  • Department of Medicine, University of Manitoba, Winnipeg, Manitoba, Canada.
  • Department of Medicine, Internal Medicine, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
  • Psychiatric Epidemiology and Psychopathology Research Center, Department of Psychiatry, Lausanne University Hospital and University of Lausanne, Prilly, Switzerland.

ORCID-Profile: Isabel Ericson, Geoffroy Solelhac, Théo Imler, Kari Lambing, Magdy Younes, Pedro Marques-Vidal, Peter Vollenweider, Marie-Pierre Françoise Strippoli, Martin Preisig, Raphaël Heinzer, Nicola A Marchi

Förderung

  • GlaxoSmithKline
  • University of Lausanne (Faculty of Biology and Medicine)
  • Swiss Personalized Health Network
  • Leenaards Foundation
  • Ligue Pulmonaire Vaudoise
  • Swiss National Science Foundation
  • Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
  • Université de Lausanne

Zitieren

APA

Ericson, I., Solelhac, G., Imler, T., Lambing, K., Younes, M., Marques-Vidal, P., Vollenweider, P., Strippoli, M. F., Preisig, M., Heinzer, R., & Marchi, N. A. (2026). Insomnia Symptoms in a Swiss Population‐Based Cohort: Prevalence, Clinical Correlates and Polysomnographic Alterations. Journal of Sleep Research, 35(5). https://doi.org/10.1111/jsr.70376

Vancouver

Ericson I, Solelhac G, Imler T, Lambing K, Younes M, Marques-Vidal P, et al. Insomnia Symptoms in a Swiss Population‐Based Cohort: Prevalence, Clinical Correlates and Polysomnographic Alterations. Journal of Sleep Research. 2026;35(5). doi:10.1111/jsr.70376

BibTeX
@article{Ericson2026,
  author = {Ericson, Isabel and Solelhac, Geoffroy and Imler, Théo and Lambing, Kari and Younes, Magdy and Marques-Vidal, Pedro and Vollenweider, Peter and Strippoli, Marie-Pierre Françoise and Preisig, Martin and Heinzer, Raphaël and Marchi, Nicola A},
  title = {Insomnia Symptoms in a Swiss Population‐Based Cohort: Prevalence, Clinical Correlates and Polysomnographic Alterations},
  journal = {Journal of Sleep Research},
  year = {2026},
  volume = {35},
  number = {5},
  doi = {10.1111/jsr.70376}
}
Kostenlos starten →